Email this article Role of ascorbic acid and tocopherol in the prevention and treatment of diseases from the standpoint of evidence-based medicine
- Authors: Shikh EV1, Makhova AA1
-
Affiliations:
- Issue: Vol 87, No 4 (2015)
- Pages: 98-102
- Section: Editorial
- URL: https://ter-arkhiv.ru/0040-3660/article/view/31764
- ID: 31764
Cite item
Full Text
Abstract
The role of vitamin C and vitamin E in the prevention and treatment of diseases is analyzed from the standpoint of evidence-based medicine. The high provision of a patient with the vitamins has a therapeutic and preventive impact on the development and course of a number of diseases. Furthermore, when additionally prescribing the vitamins as part of combination therapy, it is necessary to take into account possible drug interactions, including those due to the inducing effect of the above antioxidants on cytochrome P450 3A4.
References
- ЗайцевВ.Г., Островский О.В., Закревский В.И. Связь между химическим строением и мишенью действия как основа классификации антиоксидантов прямого действия. Экспериментальная и клиническая фармакология 2003; 4 (66): 66—70.
- Владимиров Ю.А. Свободные радикалы и антиоксиданты. Вестник Российской академии медицинских наук 1998; 7: 43—51.
- Bruno R.S., Leonard S.W., Atkinson J., Montine T.J., Ramakrishnan R., Bray T.M., Traber M.G. Faster plasma vitamin E disappearance in smokers is normalized by vitamin C supplementation. Free Radic Biol Med 2006; 40 (4): 689—697.
- http://lpi.oregonstate.edu/infocenter/vitamins/vitaminE/
- Ye Z., Song H. Antioxidant vitamins intake and the risk of coronary heart disease: meta-analysis of cohort studies. Eur J Cardiovasc Prev Rehabil 2008; 15 (1): 26—34.
- Losonczy K.G., Harris T.B., Havlik R.J. Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: the Established Populations for Epidemiologic Studies of the Elderly. Am J Clin Nutr 1996; 64 (2): 190—196.
- http://lpi.oregonstate.edu/infocenter/vitamins/vitaminC/
- Lee D.H., Folsom A.R., Harnack L., Halliwell B., Jacobs D.R., Jr. Does supplemental vitamin C increase cardiovascular disease risk in women with diabetes? Am J Clin Nutr 2004; 80 (5): 1194—1200.
- Levy A.P., Friedenberg P., Lotan R., Ouyang P., Tripputi M., Higginson L., Cobb F.R., Tardif J.C., Bittner V., Howard B.V. The effect of vitamin therapy on the progression of coronary artery atherosclerosis varies by haptoglobin type in postmenopausal women. Diabetes Care 2004; 27 (4): 925—930.
- Miller E.R., Pastor-Barriuso R., Dalal D., Riemersma R.A., Appel L.J., Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005; 142 (1): 37—46.
- Lee I.M., Cook N.R., Gaziano J.M., Gordon D., Ridker P.M., Manson J.E., Hennekens C.H., Buring J.E. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women’s Health Study: a randomized controlled trial. JAMA 2005; 294 (1): 56—65.
- Glynn R.J., Ridker P.M., Goldhaber S.Z., Zee R.Y., Buring J.E. Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women’s Health Study. Circulation 2007; 116 (13): 1497—1503.
- Myint P.K., Luben R.N., Welch A.A., Bingham S.A., Wareham N.J., Khaw K.T. Plasma vitamin C concentrations predict risk of incident stroke over 10 y in 20 649 participants of the European Prospective Investigation into Cancer Norfolk prospective population study. Am J Clin Nutr 2008; 87 (1): 64—69.
- Gokce N., Keaney J.F., Jr., Frei B., Holbrook М., Olesiak М., Zachariah В.J., Leeuwenburgh С., Heinecke О.W., Vita J.A. Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1999; 99 (25): 3234—3240.
- Boaz M., Smetana S., Weinstein T., Matas Z., Gafter U., Iaina A., Knecht A., Weissgarten Y., Brunner D., Fainaru M., Green M.S. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomized placebo-controlled trial. Lancet 2000; 356 (9237): 1213—1218.
- Rapola J.M., Virtamo J., Ripatti S., Haukka J., Huttunen J., Albanes D., Taylor P. Randomized trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet 1997; 349 (9067): 1715—1720.
- Vivekananthan D.P., Penn M.S., Sapp S.K., Hsu A., Topol E.J. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomized trials. Lancet 2003; 361 (9374): 2017—2023.
- BjelakovicG., Nikolova D., Gluud L.L., Simonetti R.G., Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 2007; 297 (8): 842—857.
- Brown B.G., Zhao X.Q., Chait A., Fisher L.D., Cheung M.C., Morse J.S., Dowdy A.A., Marino E.K., Bolson E.L., Alaupovic P., Frohlich J., Albers J.J. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 2001; 345 (22): 1583—1592.
- Collins R., Peto R., Armitage J. The MRC/BHF Heart Protection Study: preliminary results. Int J Clin Pract 2002; 56 (1): 53—56.
- Махова А.А., Шумянцева В.В., Ших Е.В., Булко Т.В., Кукес В.Г., Сизова О.С. Раменская Г.В. Арчаков А.И. Влияние витаминов группы В на монооксигеназную активность цитохрома CYP3А4: электроанализ каталитических свойств. Биомедицина 2010; 3: 99—100.
- Shumyantseva V.V., Makhova A.A., Bulko T.V., Kuzikov A.V., Shich E.V., Suprun E.V., Kukes V., Usanov S., Archakov A. The dose-dependent influence of antioxidant vitamins on electrochemically-driven cytochrome P450 catalysis. Oxid Antioxid Med Sci. Online First: 07 May, 2013. doi: 10.5455/oams.010413.or.034
Supplementary files
